WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 597124

CAS#: 13934-03-7

Description: Pyridoxylideneglutamate, in conjunction with technetium is a hepatobiliary radiopharmaceutical.

Chemical Structure

CAS# 13934-03-7

Theoretical Analysis

MedKoo Cat#: 597124
Name: Pyridoxylideneglutamate
CAS#: 13934-03-7
Chemical Formula: C13H16N2O6
Exact Mass: 296.10
Molecular Weight: 296.280
Elemental Analysis: C, 52.70; H, 5.44; N, 9.46; O, 32.40

Price and Availability

Size Price Availability Quantity
1g USD 340
Bulk inquiry

Synonym: Pyridoxylideneglutamate; Pyridoxyl glutamic acid;

IUPAC/Chemical Name: (S,E)-2-(((3-hydroxy-5-(hydroxymethyl)-2-methylpyridin-4-yl)methylene)amino)pentanedioic acid


InChi Code: InChI=1S/C13H16N2O6/c1-7-12(19)9(8(6-16)4-14-7)5-15-10(13(20)21)2-3-11(17)18/h4-5,10,16,19H,2-3,6H2,1H3,(H,17,18)(H,20,21)/b15-5+/t10-/m0/s1

SMILES Code: O=C(O)CC[C@@H](C(O)=O)/N=C/C1=C(O)C(C)=NC=C1CO

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: To be determined

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Product Data:
Biological target: Pyridoxylideneglutamate is a biochemical.
In vitro activity: To be determined
In vivo activity: To be determined

Preparing Stock Solutions

The following data is based on the product molecular weight 296.28 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol: To be determined
In vitro protocol: To be determined
In vivo protocol: To be determined

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.


Dilution Calculator

Calculate the dilution required to prepare a stock solution.

1: Choy D, Shi EC, McLean RG, Hoschl R, Murray IP, Ham JM. Cholescintigraphy in acute cholecystitis: use of intravenous morphine. Radiology. 1984 Apr;151(1):203-7. PubMed PMID: 6701315.

2: Clarke DN, Sharp PF, Brunt PW, Mowat NA, Dascombe G, Smith FW. Hepatobiliary imaging using Tc-pyridoxylideneglutamate in the diagnosis of obstructive jaundice. Eur J Nucl Med. 1982;7(8):370-5. PubMed PMID: 7117279.

3: Huang MJ, Liaw YF, Wu CS. Comparison of intravenous radionuclide cholescintigraphy and endoscopic retrograde cholangiography in the diagnosis of intrahepatic gall-stones. Br J Radiol. 1981 Apr;54(640):302-6. PubMed PMID: 7225718.

4: Hall AW, Wisbey ML, Hutchinson F, Wood RA, Cuschieri A. The place of hepatobiliary isotope scanning in the diagnosis of gallbladder disease. Br J Surg. 1981 Feb;68(2):85-90. PubMed PMID: 7459628.

5: Rao BK, Pastakia B, Lieberman LM. Evaluation of focal defects on technetium-99m sulfur colloid scans with new hepatobiliary agents. Radiology. 1980 Aug;136(2):497-9. PubMed PMID: 7403530.

6: Rao BK, Lieberman LM. Bile layering: a cause for false-positive cholescintiscans. AJR Am J Roentgenol. 1980 Jun;134(6):1251-3. PubMed PMID: 6770639.

7: Delalande JP, Mosnier H, Behar A, Picard D, Alexandre JH. [Diagnosis of jaundice with conjugated bilirubin. Dynamic scintigraphy of the bile ducts with technetium 99m pyridoxylidene glutamate]. Med Chir Dig. 1980;9(1):15-20. French. PubMed PMID: 7392694.

8: Yeh SH, Liu OK, Huang MJ. Sequential scintiphotography with technetium-99m pyridoxylideneglutamate in the detection of intrahepatic lithiasis: concise communication. J Nucl Med. 1980 Jan;21(1):17-21. PubMed PMID: 7356735.

9: Huang MJ, Yeh HR, Liaw YF. [Diagnostic value of Tc-99m-pyridoxylideneglutamate cholescintigraphy in gall bladder diseases (author's transl)]. Taiwan Yi Xue Hui Za Zhi. 1979 Mar;78(3):252-7. Chinese. PubMed PMID: 286014.

10: Klingensmith WC 3rd, Fritzberg AR, Koep LJ, Ronai PM. A clinical comparison of 99mTc-diethyl-iminodiacetic acid, 99mTc-pyridoxylideneglutamate, and 131I-rose bengal in liver transplant patients. Radiology. 1979 Feb;130(2):435-41. PubMed PMID: 366664.

11: Koven IH, Greyson ND, Newman A, Rotstein L, Reznick R. Radionuclide test for gastric bile reflux. Can J Surg. 1978 Sep;21(5):422-4. PubMed PMID: 719566.

12: Jansholt AL, Krohn KA, Stadalnik RC, Matolo NM, DeNardo GL. Catabolism and protein binding of Tc-99m pyridoxylideneglutamate. J Nucl Med. 1978 Sep;19(9):1036-44. PubMed PMID: 99499.

13: Stadalnik RC, Kraus JF, Matolo NM, Krohn KA. The validity of 99mTc-pyridoxylideneglutamate (P.G.) cholescintigraphy as a diagnostic test for cholecystitis. Clin Nucl Med. 1978 Apr;3(4):142-6. PubMed PMID: 657680.

14: Tanimura H, Mukaihara S, Maruyama K, Takenaka M, Kobayashi N, Setoyama M, Kamata T, Nagase M, Hikasa Y, Odori T, Morita R, Torizuka K. [Clinical significance of 99mTc-pyridoxylideneglutamate cholescintigraphy in the biliary tract diseases (author's transl)]. Nihon Geka Hokan. 1978 Mar 1;47(2):199-208. Japanese. PubMed PMID: 666501.

15: Yeh SH, Stadalnik RC, DeNardo GL, Chau WK. Definitive diagnosis of choledochal cyst by 99mTc-pyridoxylideneglutamate sequential scintiphotography. Clin Nucl Med. 1978 Feb;3(2):49-52. PubMed PMID: 657652.

16: Stadalnik RC, Matolo NM. Value of technetium-99m-P.G. (pyridoxylideneglutamate) scintigraphy in the evaluation of the jaundiced patient. Int J Nucl Med Biol. 1978;5(4-5):176-82. PubMed PMID: 744697.

17: Stadalnik RC, Rosenquist CJ. A comparative study of intravenous cholangiography and 99mTc-pyridoxylideneglutamate in patients with hepatobiliary disease. Gastrointest Radiol. 1977 Oct 25;2(2):141-4. PubMed PMID: 615815.

18: Baker RJ, Marion MA. Biliary scanning with Tc-99m pyridoxylideneglutamate--the effect of food in normal subjects: concise communication. J Nucl Med. 1977 Aug;18(8):793-5. PubMed PMID: 874165.

19: Wistow BW, Subramanian G, Heertum RL, Henderson RW, Gagne GM, Hall RC, McAfee JG. An evaluation of 99mTc-labeled hepatobiliary agents. J Nucl Med. 1977 May;18(5):455-61. PubMed PMID: 870637.

20: Williams JA, Baker RJ, Walsh JF, Marion MA. The role of biliary scanning in the investigation of the surgically jaundiced patient. Surg Gynecol Obstet. 1977 Apr;144(4):525-30. PubMed PMID: 847606.